Literature DB >> 15668414

Distal symmetric polyneuropathy: a definition for clinical research: report of the American Academy of Neurology, the American Association of Electrodiagnostic Medicine, and the American Academy of Physical Medicine and Rehabilitation.

J D England, G S Gronseth, G Franklin, R G Miller, A K Asbury, G T Carter, J A Cohen, M A Fisher, J F Howard, L J Kinsella, N Latov, R A Lewis, P A Low, A J Sumner.   

Abstract

The objective of this report was to develop a case definition of distal symmetric polyneuropathy to standardize and facilitate clinical research and epidemiologic studies. A formalized consensus process was employed to reach agreement after a systematic review and classification of evidence from the literature. The literature indicates that symptoms alone have relatively poor diagnostic accuracy in predicting the presence of polyneuropathy; signs are better predictors of polyneuropathy than symptoms; and single abnormalities on examination are less sensitive than multiple abnormalities in predicting the presence of polyneuropathy. The combination of neuropathic symptoms, signs, and electrodiagnostic findings provides the most accurate diagnosis of distal symmetric polyneuropathy. A set of case definitions was rank ordered by likelihood of disease. The highest likelihood of polyneuropathy (useful for clinical trials) occurs with a combination of multiple symptoms, multiple signs, and abnormal electrodiagnostic studies. A modest likelihood of polyneuropathy (useful for field or epidemiologic studies) occurs with a combination of multiple symptoms and multiple signs when the results of electrodiagnostic studies are not available. A lower likelihood of polyneuropathy occurs when electrodiagnostic studies and signs are discordant. For research purposes, the best approach to defining distal symmetric polyneuropathy is a set of case definitions rank ordered by estimated likelihood of disease. The inclusion of this formalized case definition in clinical and epidemiologic research studies will ensure greater consistency of case selection.

Entities:  

Mesh:

Year:  2005        PMID: 15668414     DOI: 10.1212/01.WNL.0000149522.32823.EA

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  181 in total

Review 1.  Role of advanced glycation endproducts and glyoxalase I in diabetic peripheral sensory neuropathy.

Authors:  Megan Jack; Douglas Wright
Journal:  Transl Res       Date:  2012-01-10       Impact factor: 7.012

2.  Restless legs syndrome in dialysis patients: a comparison between hemodialysis and continuous ambulatory peritoneal dialysis.

Authors:  Giovanni Merlino; Simone Lorenzut; Giulio Romano; Martina Sommaro; Augusto Fontana; Domenico Montanaro; Mariarosaria Valente; Gian Luigi Gigli
Journal:  Neurol Sci       Date:  2012-01-22       Impact factor: 3.307

3.  The meaning of distal sensory loss and absent ankle reflexes in relation to age: a meta-analysis.

Authors:  Alexander F J E Vrancken; Sandra Kalmijn; Frans Brugman; Gabriël J E Rinkel; Nicolette C Notermans
Journal:  J Neurol       Date:  2005-11-23       Impact factor: 4.849

Review 4.  Screening for the high-risk foot of ulceration: tests of somatic and autonomic nerve function.

Authors:  Vasiliki Argiana; Ioanna Eleftheriadou; Nicholas Tentolouris
Journal:  Curr Diab Rep       Date:  2011-08       Impact factor: 4.810

5.  Simplification of the research diagnosis of HIV-associated sensory neuropathy.

Authors:  Scott R Evans; David B Clifford; Douglas W Kitch; Karl Goodkin; Giovanni Schifitto; Justin C McArthur; David M Simpson
Journal:  HIV Clin Trials       Date:  2008 Nov-Dec

6.  Factors associated with distal symmetric polyneuropathies in adult Zambians: A cross-sectional, observational study of the role of HIV, non-antiretroviral medication exposures, and nutrition.

Authors:  Michelle Kvalsund; Takondwa Chidumayo; Johanna Hamel; David Herrmann; Douglas Heimburger; Amanda Peltier; Gretchen Birbeck
Journal:  J Neurol Sci       Date:  2018-02-22       Impact factor: 3.181

7.  Neuromuscular manifestations in hereditary haemochromatosis.

Authors:  S F Wouthuis; C Th B M van Deursen; M P te Lintelo; C A M Rozeman; R Beekman
Journal:  J Neurol       Date:  2010-04-01       Impact factor: 4.849

8.  Chemotherapy-Induced Peripheral Neuropathy in Long-term Survivors of Childhood Cancer: Clinical, Neurophysiological, Functional, and Patient-Reported Outcomes.

Authors:  Tejaswi Kandula; Michelle Anne Farrar; Richard J Cohn; David Mizrahi; Kate Carey; Karen Johnston; Matthew C Kiernan; Arun V Krishnan; Susanna B Park
Journal:  JAMA Neurol       Date:  2018-08-01       Impact factor: 18.302

9.  In-vivo reflectance confocal microscopy of Meissner's corpuscles in diabetic distal symmetric polyneuropathy.

Authors:  Peter D Creigh; Michael P McDermott; Janet E Sowden; Michele Ferguson; David N Herrmann
Journal:  J Neurol Sci       Date:  2017-05-12       Impact factor: 3.181

10.  Prevalence and risk factors for bothersome lower urinary tract symptoms in women with diabetes mellitus from hospital-based diabetes clinic.

Authors:  Abdalla M Fayyad; Simon R Hill; Geraint Jones
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2009-07-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.